GGrantIndex
← Leaderboards

Andrew J Morris

Central Arkansas Veterans Hlthcare Sys

$11,108,633
Attributed
$12,179,350
Total exposure
22
Grants
18
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY200525
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$12,179,350 · 15
VA$0 · 7

By mechanism

R01$5,912,498 · 3
P42$2,476,940 · 3
P30$2,128,128 · 2
S10$950,786 · 3
P20$680,998 · 2
R13$30,000 · 2

Top collaborators

Most similar at Central Arkansas Veterans Hlthcare Sys

Same institution · by research overlap

Others in their field

Top investigators on “Cardiovascular Diseases

Research focus

Cardiovascular DiseasesFundingMass Spectrum AnalysisBaseLipid MetabolismResearch PersonnelLipidsServicesInstrumentationProgramsCellsDisorder RiskKentuckyAreaLaboratoriesResearch Project GrantsBiological MarkersSmall MoleculeDiagnosisUnited States National Institutes Of HealthDietSignal TransductionHigh Pressure Liquid ChromatographyResolution

Grant awards (76)

BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2025 · VA · contact PI
Biomonitoring and Environmental Analytical Chemistry Core$129,768
P42 · FY2024 · ES · contact PI
Serum Amyloid as a Critical mediator between inflammation and thrombosis$0
I01 · FY2024 · VA · contact PI
Lysophosphatidic Acid and Cardiovascular Disease Risk$0
I01 · FY2024 · VA · contact PI
BLRD Research Career Scientist Award Application$0
IK6 · FY2024 · VA · contact PI
Biomonitoring and Environmental Analytical Chemistry Core$101,600
P42 · FY2023 · ES · contact PI
Lysophosphatidic Acid and Cardiovascular Disease Risk$0
I01 · FY2023 · VA · contact PI
Core B - Analytical Core$352,318
P30 · FY2022 · GM · contact PI
Biomonitoring and Environmental Analytical Chemistry Core$101,600
P42 · FY2022 · ES · contact PI
Lysophosphatidic Acid and Cardiovascular Disease Risk$0
I01 · FY2022 · VA · contact PI
Analytical Services Core$202,162
P30 · FY2021 · ES · contact PI
Core B - Analytical Core$191,250
P30 · FY2021 · GM · contact PI
Biomonitoring and Environmental Analytical Chemistry Core$101,600
P42 · FY2021 · ES · contact PI
Lysophosphatidic acid and cardiovascular disease risk$0
I01 · FY2021 · VA · contact PI
Lysophosphatidic Acid and Cardiovascular Disease Risk$0
I01 · FY2021 · VA · contact PI
Analytical Services Core$202,162
P30 · FY2020 · ES · contact PI
Core B - Analytical Core$191,250
P30 · FY2020 · GM · contact PI
Biomonitoring and Environmental Analytical Chemistry Core$152,399
P42 · FY2020 · ES · contact PI
Serum Amyloid as a Critical mediator between inflammation and thrombosis$0
I01 · FY2020 · VA · contact PI
Research Support Core - Core B$299,036
P42 · FY2019 · ES · contact PI
Analytical Services Core$202,162
P30 · FY2019 · ES · contact PI
Core B - Analytical Core$191,250
P30 · FY2019 · GM · contact PI
Lysophosphatidic acid and cardiovascular disease risk$0
I01 · FY2019 · VA · contact PI
ShEEP Request For Gas Chromatograph Mass Spectrometer$0
IS1 · FY2019 · VA · contact PI
Lipid phosphate phosphatase 3 as a novel atherosclerosis suppressor$544,681
R01 · FY2018 · HL
Research Support Core - Core B$356,588
P42 · FY2018 · ES · contact PI
Analytical Services Core$202,162
P30 · FY2018 · ES · contact PI
Core B - Analytical Core$191,250
P30 · FY2018 · GM · contact PI
Research Support Core - Core B$1,000
P42 · FY2018 · ES · contact PI
Lysophosphatidic acid and cardiovascular disease risk$0
I01 · FY2018 · VA · contact PI
Lipid phosphate phosphatase 3 as a novel atherosclerosis suppressor$542,107
R01 · FY2017 · HL
Triple Quadrupole Mass Spectrometer System$352,381
S10 · FY2017 · OD · contact PI
Research Support Core - Core B$304,460
P42 · FY2017 · ES · contact PI
Analytical Services Core$202,162
P30 · FY2017 · ES · contact PI
Analytical Core B$112,875
P20 · FY2017 · GM · contact PI
Lysophosphatidic acid and cardiovascular disease risk$0
I01 · FY2017 · VA · contact PI
Lipid phosphate phosphatase 3 as a novel atherosclerosis suppressor$533,513
R01 · FY2016 · HL
Research Support Core - Core B$307,677
P42 · FY2016 · ES · contact PI
Analytical Core B$112,875
P20 · FY2016 · GM · contact PI
Association of a common variant of the PPAP2B gene with cardiovascular disease.$0
I01 · FY2016 · VA · contact PI
Lipid phosphate phosphatase 3 as a novel atherosclerosis suppressor$521,134
R01 · FY2015 · HL
Research Support Core - Core B$310,755
P42 · FY2015 · ES · contact PI
Analytical Core B$112,875
P20 · FY2015 · GM · contact PI
Association of a common variant of the PPAP2B gene with cardiovascular disease.$0
I01 · FY2015 · VA · contact PI
Acquisition of an HPLC Electrospray/chemical ionization triple quadrupole linear ion trap mass spectrometer system.$0
IS1 · FY2015 · VA · contact PI
Research Support Core - Core B$310,457
P42 · FY2014 · ES · contact PI
Analytical Core B$112,528
P20 · FY2014 · GM · contact PI
Association of a common variant of the PPAP2B gene with cardiovascular disease.$0
I01 · FY2014 · VA · contact PI
Analytical Core B$112,500
P20 · FY2013 · GM · contact PI
Association of a common variant of the PPAP2B gene with cardiovascular disease.$0
I01 · FY2013 · VA · contact PI
Role of Lipid Phosphatases in Cholesterol and Triglyceride Synthesis$276,401
R01 · FY2011 · GM · contact PI
ANALYTICAL CORE$117,345
P20 · FY2011 · RR · contact PI
Advion Triversa Nanomate/ABSciex Nanospray III Ion Source for Targeted Lipidomics$105,745
S10 · FY2011 · RR · contact PI
Role of Lipid Phosphatases in Cholesterol and Triglyceride Synthesis$279,193
R01 · FY2010 · GM · contact PI
Role of Lipid Phosphatases in Cholesterol and Triglyceride Synthesis$99,633
R01 · FY2010 · GM · contact PI
Role of Lipid Phosphatases in Cholesterol and Triglyceride Synthesis$282,013
R01 · FY2009 · GM · contact PI
Thermo/Finnigan TSQ AM Triple Stage Quadrupole Mass Spectrometer$492,660
S10 · FY2008 · RR · contact PI
Role of Lipid Phosphatases in Cholesterol and Triglyceride Synthesis$67,566
R01 · FY2008 · GM · contact PI
Lysophosphatidic Acid: Synthesis, Actions & Inactivation$218,633
R01 · FY2007 · GM · contact PI
Lysophosphatidic Acid: Synthesis, Actions & Inactivation$225,162
R01 · FY2006 · GM · contact PI
Lysophosphatidic Acid: Synthesis, Actions &Inactivation$211,667
R01 · FY2005 · GM
Lysophospholipid Mediators in Ovarian Cancer$188,265
R01 · FY2005 · CA
Lysophospholipid Mediators in Ovarian Cancer$70,725
R01 · FY2005 · CA
FASEB SUMMER RESEARCH CONFERENCE: BIOACTIVE LYSOLIPIDS$20,000
R13 · FY2005 · HL
Lysophosphatidic Acid: Synthesis, Actions &Inactivation$5,001
R01 · FY2005 · GM
Lysophospholipid Mediators in Ovarian Cancer$317,390
R01 · FY2004 · CA
Lysophosphatidic Acid: Synthesis, Actions &Inactivation$265,942
R01 · FY2004 · GM
FASEB Summer Conference on Phospholipases$10,000
R13 · FY2004 · AI
Lysophospholipid Mediators in Ovarian Cancer$258,990
R01 · FY2003 · CA
PHOSPHATIDYLCHOLINE SIGNALING$192,574
R01 · FY2003 · GM
Lysophospholipid Mediators in Ovarian Cancer$258,990
R01 · FY2002 · CA
PHOSPHATIDYLCHOLINE SIGNALING$187,034
R01 · FY2002 · GM
PHOSPHATIDYLCHOLINE SIGNALING$116,703
R01 · FY2001 · GM
PHOSPHATIDYLCHOLINE SIGNALING$66,990
R01 · FY2001 · GM
PHOSPHATIDYLCHOLINE SIGNALING$182,191
R01 · FY2000 · GM